[Guideline] American College of Radiology. ACR Manual on Contrast Media v10.3. 2017. Available at https://www.acr.org/~/media/37D84428BF1D4E1B9A3A2918DA9E27A3.pdf.
Dillman JR, Ellis JH, Cohan RH, Strouse PJ, Jan SC. Allergic-like breakthrough reactions to gadolinium contrast agents after corticosteroid and antihistamine premedication. AJR Am J Roentgenol. 2008 Jan. 190(1):187-90. [QxMD MEDLINE Link].
Dillman JR, Ellis JH, Cohan RH, Strouse PJ, Jan SC. Frequency and severity of acute allergic-like reactions to gadolinium-containing i.v. contrast media in children and adults. AJR Am J Roentgenol. 2007 Dec. 189(6):1533-8. [QxMD MEDLINE Link].
Goel G, Ravishankar S, Jayakumar PN, et al. Intrathecal gadolinium-enhanced magnetic resonance cisternography in cerebrospinal fluid rhinorrhea: road ahead?. J Neurotrauma. 2007 Oct. 24(10):1570-5. [QxMD MEDLINE Link].
Kalogeromitros DC, Makris MP, Rouvas A, et al. Skin testing and adverse reactions in fluorescein: a prospective study. Allergy Asthma Proc. 2007 Jul-Aug. 28(4):472-6. [QxMD MEDLINE Link].
Lira RP, Oliveira CL, Marques MV, et al. Adverse reactions of fluorescein angiography: a prospective study. Arq Bras Oftalmol. 2007 Jul-Aug. 70(4):615-8. [QxMD MEDLINE Link]. [Full Text].
Thomsen HS. Imaging patients with chronic kidney disease: CIN or NSF?. Radiol Med (Torino). 2007 Aug. 112(5):621-5. [QxMD MEDLINE Link].
Thomsen HS, Marckmann P, Logager VB. Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents. Cancer Imaging. 2007. 7:130-7. [QxMD MEDLINE Link]. [Full Text].
Tubek S, Tubek I. Significance of zinc in nephrotoxicity of contrast media used in imaging diagnostics of the cardiovascular system. Biol Trace Elem Res. 2007. 117(1-3):1-5. [QxMD MEDLINE Link].
Lightfoot CB, Abraham RJ, Mammen T, Abdolell M, Kapur S, Abraham RJ. Survey of radiologists' knowledge regarding the management of severe contrast material-induced allergic reactions. Radiology. 2009 Jun. 251(3):691-6. [QxMD MEDLINE Link].
Callahan MJ, Poznauskis L, Zurakowski D, Taylor GA. Nonionic iodinated intravenous contrast material-related reactions: incidence in large urban children's hospital--retrospective analysis of data in 12,494 patients. Radiology. 2009 Mar. 250(3):674-81. [QxMD MEDLINE Link].
Pan JJ, Draganov PV. Adverse reactions to iodinated contrast media administered at the time of endoscopic retrograde cholangiopancreatography (ERCP). Inflamm Allergy Drug Targets. 2009 Mar. 8(1):17-20. [QxMD MEDLINE Link].
Brockow K, Romano A, Aberer W, Bircher AJ, Barbaud A, Bonadonna P, et al. Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study. Allergy. 2009 Feb. 64(2):234-41. [QxMD MEDLINE Link].
Bednarczuk T, Brix TH, Schima W, Zettinig G, Kahaly GJ. 2021 European Thyroid Association Guidelines for the Management of Iodine-Based Contrast Media-Induced Thyroid Dysfunction. Eur Thyroid J. 2021 Jul. 10 (4):269-284. [QxMD MEDLINE Link].
[Guideline] European Society of Urogenital Radiology. ESUR Guidelines on Contrast Agents. European Society of Urogenital Radiology. Available at https://www.esur.org/wp-content/uploads/2022/03/ESUR-Guidelines-10_0-Final-Version.pdf. March 2018; Accessed: January 20, 2023.
Mruk B. Renal Safety of Iodinated Contrast Media Depending on Their Osmolarity - Current Outlooks. Pol J Radiol. 2016. 81:157-65. [QxMD MEDLINE Link].
Bucher AM, De Cecco CN, Schoepf UJ, Meinel FG, Krazinski AW, Spearman JV, et al. Is contrast medium osmolality a causal factor for contrast-induced nephropathy?. Biomed Res Int. 2014. 2014:931413. [QxMD MEDLINE Link]. [Full Text].
Gaca AM, Frush DP, Hohenhaus SM, et al. Enhancing pediatric safety: using simulation to assess radiology resident preparedness for anaphylaxis from intravenous contrast media. Radiology. 2007 Oct. 245(1):236-44. [QxMD MEDLINE Link].
Cutroneo P, Polimeni G, Curcuruto R, Calapai G, Caputi AP. Adverse reactions to contrast media: an analysis from spontaneous reporting data. Pharmacol Res. 2007 Jul. 56(1):35-41. [QxMD MEDLINE Link].
Cohan RH, Ellis JH. Iodinated contrast material in uroradiology. Choice of agent and management of complications. Urol Clin North Am. 1997 Aug. 24(3):471-91. [QxMD MEDLINE Link].
Cohan RH, Ellis JH, Dunnick NR. Use of low-osmolar agents and premedication to reduce the frequency of adverse reactions to radiographic contrast media: a survey of the Society of Uroradiology. Radiology. 1995 Feb. 194(2):357-64. [QxMD MEDLINE Link]. [Full Text].
Marshall GD Jr, Lieberman PL. Comparison of three pretreatment protocols to prevent anaphylactoid reactions to radiocontrast media. Ann Allergy. 1991 Jul. 67(1):70-4. [QxMD MEDLINE Link].
Katayama H, Yamaguchi K, Kozuka T, et al. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology. 1990 Jun. 175(3):621-8. [QxMD MEDLINE Link]. [Full Text].
Lasser EC, Berry CC, Talner LB, et al. Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material. N Engl J Med. 1987 Oct 1. 317(14):845-9. [QxMD MEDLINE Link].
Wolf GL, Arenson RL, Cross AP. A prospective trial of ionic vs nonionic contrast agents in routine clinical practice: comparison of adverse effects. AJR Am J Roentgenol. 1989 May. 152(5):939-44. [QxMD MEDLINE Link]. [Full Text].
Dillman JR, Strouse PJ, Ellis JH, Cohan RH, Jan SC. Incidence and severity of acute allergic-like reactions to i.v. nonionic iodinated contrast material in children. AJR Am J Roentgenol. 2007 Jun. 188(6):1643-7. [QxMD MEDLINE Link].
Caro JJ, Trindade E, McGregor M. The risks of death and of severe nonfatal reactions with high- vs low-osmolality contrast media: a meta-analysis. AJR Am J Roentgenol. 1991 Apr. 156(4):825-32. [QxMD MEDLINE Link]. [Full Text].
Kinnison ML, Powe NR, Steinberg EP. Results of randomized controlled trials of low-versus high-osmolality contrast media. Radiology. 1989 Feb. 170(2):381-9. [QxMD MEDLINE Link]. [Full Text].
Memolo M, Dyer R, Zagoria RJ. Extravasation injury with nonionic contrast material [letter]. AJR Am J Roentgenol. 1993 Jan. 160(1):203-4. [QxMD MEDLINE Link]. [Full Text].
Foord KD, Kaye B, Howard J, Cumberland DC. Comparison of the side-effects of low-osmolar contrast media in intravenous urography. Clin Radiol. 1985 Jul. 36(4):379-80. [QxMD MEDLINE Link].
Bush WH, Swanson DP. Acute reactions to intravascular contrast media: types, risk factors, recognition, and specific treatment. AJR Am J Roentgenol. 1991 Dec. 157(6):1153-61. [QxMD MEDLINE Link]. [Full Text].
Becker C. [Prophylaxis and treatment of side effects due to iodinated contrast media relevant to radiological practice] [German]. Radiologe. 2007 Sep. 47(9):768-73. [QxMD MEDLINE Link].
Iakovou I, Zapandiotis A, Mpalaris V, Goulis DG. Radio-contrast agent-induced hyperthyroidism: case report and review of the literature. Arch Endocrinol Metab. 2016 Feb 16. [QxMD MEDLINE Link].
Andreucci M, Solomon R, Tasanarong A. Side Effects of Radiographic Contrast Media: Pathogenesis, Risk Factors, and Prevention. BioMed Research International. Available at http://www.hindawi.com/journals/bmri/2014/741018/. 2014; Accessed: May 31, 2016.
Hudzik B, Zubelewicz-Szkodzińska B. Radiocontrast-induced thyroid dysfunction: is it common and what should we do about it?. Clin Endocrinol (Oxf). 2014 Mar. 80 (3):322-7. [QxMD MEDLINE Link]. [Full Text].
Davis PL. Anaphylactoid reactions to the nonvascular administration of water-soluble iodinated contrast media. AJR Am J Roentgenol. 2015 Jun. 204 (6):1140-5. [QxMD MEDLINE Link].
Brockow K, Sánchez-Borges M. Hypersensitivity to contrast media and dyes. Immunol Allergy Clin North Am. 2014 Aug. 34 (3):547-64, viii. [QxMD MEDLINE Link].
Behzadi AH, Zhao Y, Farooq Z, Prince MR. Immediate Allergic Reactions to Gadolinium-based Contrast Agents: A Systematic Review and Meta-Analysis. Radiology. 2018 Feb. 286 (2):471-482. [QxMD MEDLINE Link]. [Full Text].
Heshmatzadeh Behzadi A, Farooq Z, Newhouse JH, Prince MR. MRI and CT contrast media extravasation: A systematic review. Medicine (Baltimore). 2018 Mar. 97 (9):e0055. [QxMD MEDLINE Link]. [Full Text].
Egbert RE, De Cecco CN, Schoepf UJ, McQuiston AD, Meinel FG, Katzberg RW. Delayed adverse reactions to the parenteral administration of iodinated contrast media. AJR Am J Roentgenol. 2014 Dec. 203 (6):1163-70. [QxMD MEDLINE Link].
Barr ML, Chiu HK, Li N, Yeh MW, Rhee CM, Casillas J, et al. Thyroid Dysfunction in Children Exposed to Iodinated Contrast Media. J Clin Endocrinol Metab. 2016 Mar 28. jc20161330. [QxMD MEDLINE Link].
Hinson JS, Ehmann MR, Fine DM, Fishman EK, Toerper MF, Rothman RE, et al. Risk of Acute Kidney Injury After Intravenous Contrast Media Administration. Ann Emerg Med. 2017 May. 69 (5):577-586.e4. [QxMD MEDLINE Link]. [Full Text].
Azzalini L, Spagnoli V, Ly HQ. Contrast-Induced Nephropathy: From Pathophysiology to Preventive Strategies. Can J Cardiol. 2015 May 23. [QxMD MEDLINE Link].
Nicola R, Shaqdan KW, Aran K, Mansouri M, Singh A, Abujudeh HH. Contrast-Induced Nephropathy: Identifying the Risks, Choosing the Right Agent, and Reviewing Effective Prevention and Management Methods. Curr Probl Diagn Radiol. 2015 Apr 15. [QxMD MEDLINE Link].
Balemans CE, Reichert LJ, van Schelven BI, van den Brand JA, Wetzels JF. Epidemiology of Contrast Material-induced Nephropathy in the Era of Hydration. Radiology. 2012 Jun. 263(3):706-13. [QxMD MEDLINE Link].
Rose TA Jr, Choi JW. Intravenous Imaging Contrast Media Complications: The Basics That Every Clinician Needs to Know. Am J Med. 2015 Sep. 128 (9):943-9. [QxMD MEDLINE Link].
Mammarappallil JG, Hiatt KD, Vincent W, Bettmann MA. How accurate is the label "allergic to iodinated contrast agents"?. Acta Radiol. 2016 Jan. 57 (1):47-50. [QxMD MEDLINE Link].
Sesé L, Gaouar H, Autegarden JE, Alari A, Amsler E, Vial-Dupuy A, et al. Immediate hypersensitivity to iodinated contrast media: diagnostic accuracy of skin tests and intravenous provocation test with low dose. Clin Exp Allergy. 2016 Mar. 46 (3):472-8. [QxMD MEDLINE Link].
Caron J, Graf S, Delebarre-Sauvage C. Immediate hypersensitivity reactions to iodinated contrast media: The diagnosis of allergy by skin testing. Clin Transl Allergy. 2022 Dec. 12 (12):e12214. [QxMD MEDLINE Link].
Torres MJ, Trautmann A, Böhm I, et al. Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity. Allergy. 2021 May. 76 (5):1325-1339. [QxMD MEDLINE Link].
Doña I, Bogas G, Salas M, et al. Hypersensitivity Reactions to Multiple Iodinated Contrast Media. Front Pharmacol. 2020. 11:575437. [QxMD MEDLINE Link].
Subramaniam RM, Wilson RF, Turban S, Suarez-Cuervo C, Zhang A, Sherrod C, et al. Contrast-Induced Nephropathy: Comparative Effects of Different Contrast Media. 2016 Jan. [QxMD MEDLINE Link]. [Full Text].
Subramaniam RM, Suarez-Cuervo C, Wilson RF, Turban S, Zhang A, Sherrod C, et al. Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis. Ann Intern Med. 2016 Mar 15. 164 (6):406-16. [QxMD MEDLINE Link].
Eng J, Subramaniam RM, Wilson RF, Turban S, Choi MJ, Zhang A, et al. 2015 Dec. [QxMD MEDLINE Link]. [Full Text].
John M. Eisenberg Center for Clinical Decisions and Communications Science. Contrast-Induced Nephropathy (CIN): Current State of the Evidence on Contrast Media and Prevention of CIN. 2007. [QxMD MEDLINE Link]. [Full Text].
Nijssen EC, Rennenberg RJ, Nelemans PJ, Essers BA, Janssen MM, Vermeeren MA, et al. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet. 2017 Apr 1. 389 (10076):1312-1322. [QxMD MEDLINE Link].
[Guideline] European Society of Urogenital Radiology. ESUR Guidelines on Contrast Media. European Society of Urogenital Radiology.2015. Available at http://www.esur.org/guidelines/. Accessed: September 29, 2015.
[Guideline] Royal College of Radiology. Standards for intravascular contrast administration to adult patients, 3rd edition. Available at https://www.rcr.ac.uk/publication/standards-intravascular-contrast-administration-adult-patients-third-edition.
Davenport MS, Cohan RH, Ellis JH. Contrast media controversies in 2015: imaging patients with renal impairment or risk of contrast reaction. AJR Am J Roentgenol. 2015 Jun. 204 (6):1174-81. [QxMD MEDLINE Link].
Mervak BM, Davenport MS, Ellis JH, Cohan RH. Rates of Breakthrough Reactions in Inpatients at High Risk Receiving Premedication Before Contrast-Enhanced CT. AJR Am J Roentgenol. 2015 Jul. 205 (1):77-84. [QxMD MEDLINE Link].
Davenport MS, Cohan RH, Caoili EM, Ellis JH. Repeat contrast medium reactions in premedicated patients: frequency and severity. Radiology. 2009 Nov. 253(2):372-9. [QxMD MEDLINE Link].
Kolbe AB, Hartman RP, Hoskin TL, Carter RE, Maddox DE, Hunt CH, et al. Premedication of patients for prior urticarial reaction to iodinated contrast medium. Abdom Imaging. 2014 Apr. 39(2):432-7. [QxMD MEDLINE Link].
Greenberger PA, Patterson R, Radin RC. Two pretreatment regimens for high-risk patients receiving radiographic contrast media. J Allergy Clin Immunol. 1984 Oct. 74(4 pt 1):540-3. [QxMD MEDLINE Link].
Hsieh C, Wu SC, Kosik RO, Huang YC, Chan WP. Pharmacological Prevention of Hypersensitivity Reactions Caused by Iodinated Contrast Media: A Systematic Review and Meta-Analysis. Diagnostics (Basel). 2022 Jul 9. 12 (7):[QxMD MEDLINE Link].
United States Food and Drug Administration. New warnings required on use of gadolinium-based contrast agents. US Food and Drug Administration. Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm225286.htm. Accessed: September 9, 2010.
Kang HR, Jeong J, Brockow K. Diagnosis and Prevention of Hypersensitivity Reactions to Iodinated Contrast Media. Allergy Asthma Immunol Res. 2022 Jul. 14 (4):348-360. [QxMD MEDLINE Link].
Schrijvers R, Breynaert C, Ahmedali Y, et al. Skin Testing for Suspected Iodinated Contrast Media Hypersensitivity. J Allergy Clin Immunol Pract. 2018 Jul-Aug. 6 (4):1246-1254. [QxMD MEDLINE Link].
Park SJ, Kang DY, Sohn KH, et al. Immediate Mild Reactions to CT with Iodinated Contrast Media: Strategy of Contrast Media Readministration without Corticosteroids. Radiology. 2018 Sep. 288 (3):710-716. [QxMD MEDLINE Link].
Lerondeau B, Trechot P, Waton J, et al. Analysis of cross-reactivity among radiocontrast media in 97 hypersensitivity reactions. J Allergy Clin Immunol. 2016 Feb. 137 (2):633-635.e4. [QxMD MEDLINE Link].
Lee SY, Yang MS, Choi YH, et al. Stratified premedication strategy for the prevention of contrast media hypersensitivity in high-risk patients. Ann Allergy Asthma Immunol. 2017 Mar. 118 (3):339-344.e1. [QxMD MEDLINE Link].
Abe S, Fukuda H, Tobe K, Ibukuro K. Protective effect against repeat adverse reactions to iodinated contrast medium: Premedication vs. changing the contrast medium. Eur Radiol. 2016 Jul. 26 (7):2148-54. [QxMD MEDLINE Link].
Park HJ, Park JW, Yang MS, et al. Re-exposure to low osmolar iodinated contrast media in patients with prior moderate-to-severe hypersensitivity reactions: A multicentre retrospective cohort study. Eur Radiol. 2017 Jul. 27 (7):2886-2893. [QxMD MEDLINE Link].
Tepel M, Zidek W. Acetylcysteine and contrast media nephropathy. Curr Opin Nephrol Hypertens. 2002 Sep. 11(5):503-6. [QxMD MEDLINE Link].
Shehadi WH. Adverse reactions to intravascularly administered contrast media. A comprehensive study based on a prospective survey. Am J Roentgenol Radium Ther Nucl Med. 1975 May. 124(1):145-52. [QxMD MEDLINE Link].
Jensen N, Dorph S. Adverse reactions to urographic contrast medium. Rapid versus slow injection rate. Br J Radiol. 1980 Jul. 53(631):659-61. [QxMD MEDLINE Link].